Synthetic lethality from the combination of a histone methyltransferase SUV39H2 inhibitor and a poly (ADP-ribose) polymerase inhibitor for uterine leiomyosarcoma. - Toyohara Y; Sone K; Kumegawa K; Yamamoto Y; Hachijo R; Kukita A; Taguchi A; Ikemura M; Miyamoto Y; Tanikawa M; Iriyama T; Mori M; et al. (BMC cancer, 2025)